Zobrazeno 1 - 10
of 28
pro vyhledávání: '"MESH: Oncogene Proteins, Fusion"'
Autor:
Rachel Deplus, Martine Duterque-Coquillaud, Anne Flourens, Edith Bonnelye, Nathalie Vanpouille, Tian V. Tian, Philippe Clézardin, Anais Fradet, Carine Delliaux, Xavier Leroy, Yvan de Launoit, Mathilde Bouchet, Arnauld Villers
Publikováno v:
Cancer Letters
Cancer Letters, Elsevier, 2018, 438, pp.32-43. ⟨10.1016/j.canlet.2018.08.027⟩
Cancer Letters, 2018, 438, pp.32-43. ⟨10.1016/j.canlet.2018.08.027⟩
Cancer Letters, Elsevier, 2018, 438, pp.32-43. ⟨10.1016/j.canlet.2018.08.027⟩
Cancer Letters, 2018, 438, pp.32-43. ⟨10.1016/j.canlet.2018.08.027⟩
International audience; Abstract : Prostate cancers have a strong propensity to metastasize to bone and promote osteoblastic lesions. TMPRSS2:ERG is the most frequent gene rearrangement identified in prostate cancer, but whether it is involved in pro
Autor:
Anne Flourens, Carine Delliaux, Yvan de Launoit, Xavier Leroy, Rachel Deplus, Martine Duterque-Coquillaud, Nathalie Marchand, Nathalie Vanpouille
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2017, 8 (7), pp.11827-11840. ⟨10.18632/oncotarget.14399⟩
Oncotarget, 2017, 8 (7), pp.11827-11840. ⟨10.18632/oncotarget.14399⟩
Oncotarget, 8 (7
Oncotarget, Impact journals, 2017, 8 (7), pp.11827-11840. ⟨10.18632/oncotarget.14399⟩
Oncotarget, 2017, 8 (7), pp.11827-11840. ⟨10.18632/oncotarget.14399⟩
Oncotarget, 8 (7
Bone metastasis is the major deleterious event in prostate cancer (PCa). TMPRSS2-ERG fusion is one of the most common chromosomic rearrangements in PCa. However, its implication in bone metastasis development is still unclear. Since bone metastasis s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce6842a4a21bd05145fce04e57a3617d
https://hal.archives-ouvertes.fr/hal-02391621/file/TMPRSS2-ERG_fusion_promotes_prostate.pdf
https://hal.archives-ouvertes.fr/hal-02391621/file/TMPRSS2-ERG_fusion_promotes_prostate.pdf
Autor:
Dominique Figarella-Branger, Franck Bielle, Clovis Adam, Louis Royer-Perron, Guillaume Gauchotte, David Meyronet, Aurélie Bruno, Chiara Villa, Amithys Rahimian, Blandine Boisselier, Carole Soussain, Fabrice Chrétien, Khê Hoang-Xuan, Caroline Houillier, Sandrine Eimer, Mailys Daniau, Frederic Davi, Karima Mokhtari, Karim Labreche, Justine Guegan, Pierre de la Grange, Agusti Alentorn, Marc Polivka, Audrey Rousseau, Frédéric Lemoine
Publikováno v:
Neuro-Oncology
Neuro-Oncology, 2018, 20 (8), pp.1092-1100. ⟨10.1093/neuonc/noy019⟩
Neuro-Oncology, Oxford University Press (OUP), 2018, 20 (8), pp.1092-1100. ⟨10.1093/neuonc/noy019⟩
Neuro-Oncology, 2018, 20 (8), pp.1092-1100. ⟨10.1093/neuonc/noy019⟩
Neuro-Oncology, Oxford University Press (OUP), 2018, 20 (8), pp.1092-1100. ⟨10.1093/neuonc/noy019⟩
International audience; Background: Primary central nervous system lymphoma (PCNSL) represents a particular entity within non-Hodgkin lymphomas and is associated with poor outcome. The present study addresses the potential clinical relevance of chime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5cc9f95aaa08e9662341fc6bbe9c176
https://hal-pasteur.archives-ouvertes.fr/pasteur-02862388
https://hal-pasteur.archives-ouvertes.fr/pasteur-02862388
Autor:
G. Sassolas, Z. Hafdi Nejjari, A. Ferraro, M. S. Gandhi, C. Kwon Jung, E. Borbone, M. Decaussin Petrucci, B. Rousset, F. Borson Chazot, N. Berger, FUSCO, ALFREDO
Publikováno v:
Thyroid
Thyroid, Mary Ann Liebert, 2012, 22 (1), pp.17-26. ⟨10.1089/thy.2011.0215⟩
Thyroid, Mary Ann Liebert, 2012, 22 (1), pp.17-26. 〈10.1089/thy.2011.0215〉
Thyroid, Mary Ann Liebert, 2012, 22 (1), pp.17-26. ⟨10.1089/thy.2011.0215⟩
Thyroid, Mary Ann Liebert, 2012, 22 (1), pp.17-26. 〈10.1089/thy.2011.0215〉
International audience; BACKGROUND: Papillary thyroid carcinoma (PTC) in young people usually has an aggressive initial presentation, though a good general prognosis despite recurrences in 10%-20% of patients. A number of genetic alterations that act
Autor:
Christian Auclair, Franck Tirode, Olivier Delattre, Alain Lilienbaum, Julie Lagirand-Cantaloube, Marie-Hélène Kryszke, Karine Laud
Publikováno v:
Biochemical and Biophysical Research Communications
Biochemical and Biophysical Research Communications, Elsevier, 2010, 399 (4), pp.705-10. ⟨10.1016/j.bbrc.2010.08.004⟩
Biochemical and Biophysical Research Communications, Elsevier, 2010, 399 (4), pp.705-10. 〈10.1016/j.bbrc.2010.08.004〉
Biochemical and Biophysical Research Communications, Elsevier, 2010, 399 (4), pp.705-10. ⟨10.1016/j.bbrc.2010.08.004⟩
Biochemical and Biophysical Research Communications, Elsevier, 2010, 399 (4), pp.705-10. 〈10.1016/j.bbrc.2010.08.004〉
International audience; Ewing sarcoma is primarily caused by a t(11;22) chromosomal translocation encoding the EWS-FLI1 fusion protein. To exert its oncogenic function, EWS-FLI1 acts as an aberrant transcription factor, broadly altering the gene expr
Autor:
Bernard Mari, Elodie Portales-Casamar, Bruno Cassinat, Evelyne Friederich, Christine Chomienne, Khalil Arar, Pascal Barbry, Thomas Maurin, Anne Saumet, Manuella Bouttier, Laurent Vallar, Guillaume Vetter, Charles-Henri Lecellier, Wyeth W. Wasserman
Publikováno v:
Blood
Blood, American Society of Hematology, 2009, 113 (2), pp.412-21. ⟨10.1182/blood-2008-05-158139⟩
Blood, American Society of Hematology, 2009, 113 (2), pp.412-21. 〈10.1182/blood-2008-05-158139〉
Blood, American Society of Hematology, 2009, 113 (2), pp.412-21. ⟨10.1182/blood-2008-05-158139⟩
Blood, American Society of Hematology, 2009, 113 (2), pp.412-21. 〈10.1182/blood-2008-05-158139〉
Micro(mi)RNAs are small noncoding RNAs that orchestrate many key aspects of cell physiology and their deregulation is often linked to distinct diseases including cancer. Here, we studied the contribution of miRNAs in a well-characterized human myeloi
Autor:
Virginie Penard-Lacronique, Isabelle André-Schmutz, Xin-Ying Su, Roland Berger, Paola Ballerini, Claudie Lemercier, Véronique Della-Valle, Francine Mugneret, Serge Romana, Michel Lessard, Isabelle Radford-Weiss, Marina Lafage-Pochitaloff, Olivier Bernard
Publikováno v:
Blood
Blood, American Society of Hematology, 2006, 108 (13), pp.4198-201. 〈10.1182/blood-2006-07-032953〉
Blood, 2006, 108 (13), pp.4198-201. ⟨10.1182/blood-2006-07-032953⟩
Blood, American Society of Hematology, 2006, 108 (13), pp.4198-201. ⟨10.1182/blood-2006-07-032953⟩
Blood, American Society of Hematology, 2006, 108 (13), pp.4198-201. 〈10.1182/blood-2006-07-032953〉
Blood, 2006, 108 (13), pp.4198-201. ⟨10.1182/blood-2006-07-032953⟩
Blood, American Society of Hematology, 2006, 108 (13), pp.4198-201. ⟨10.1182/blood-2006-07-032953⟩
International audience; The t(5;14)(q35;q32) chromosomal translocation is specifically observed in up to 20% of childhood T-cell acute lymphoblastic leukemia (T-ALL). It affects the BCL11B/CTIP2 locus on chromosome 14 and the RANBP17-TLX3/HOX11L2 reg
Autor:
Frédéric Percevault, Christophe Tiffoche, Gilles Flouriot, Guillaume Huet, Farzad Pakdel, Jean-François Arnal, Raphaël Métivier, Noureddine Boujrad, Yohann Mérot
Publikováno v:
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2009, 284 (49), pp.33729-39. ⟨10.1074/jbc.M109.045534⟩
Journal of Biological Chemistry, 2009, 284 (49), pp.33729-39. ⟨10.1074/jbc.M109.045534⟩
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2009, 284 (49), pp.33729-39. ⟨10.1074/jbc.M109.045534⟩
Journal of Biological Chemistry, 2009, 284 (49), pp.33729-39. ⟨10.1074/jbc.M109.045534⟩
International audience; Although involved in processes leading to the emergence and development of hormone-dependent breast cancers, the estrogen receptor alpha (ERalpha) also prevents transformed cells from progressing toward a more aggressive pheno
Autor:
Cécile Rouzier, Jean Amiel, Jean-François Michiels, Laure Valério, Juliette Haudebourg, Florence Pedeutour, Xavier Carpentier
Publikováno v:
Cancer Genetics and Cytogenetics
Cancer Genetics and Cytogenetics, Elsevier, 2008, 183 (1), pp.21-7. ⟨10.1016/j.cancergencyto.2008.01.021⟩
Cancer Genetics and Cytogenetics, Elsevier, 2008, 183 (1), pp.21-7. ⟨10.1016/j.cancergencyto.2008.01.021⟩
The recent identification of fusion genes involving ETS family members in human prostate adenocarcinoma has confirmed the hypothesis that recurrent specific aberrations such as fusion genes may be as frequent in epithelial tumors as they are in leuke
Autor:
Tian V. Tian, Y. De Launoit, Xavier Leroy, Ludovic Huot, Nathalie Tomavo, Martine Duterque-Coquillaud, Anne Flourens, Sébastien Flajollet, Edith Bonnelye, David Hot
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 2014, 33 (17), pp.2204-2214. ⟨10.1038/onc.2013.176⟩
Oncogene, 2014, 33 (17), pp.2204-2214. ⟨10.1038/onc.2013.176⟩
Oncogene, Nature Publishing Group, 2014, 33 (17), pp.2204-2214. ⟨10.1038/onc.2013.176⟩
Oncogene, 2014, 33 (17), pp.2204-2214. ⟨10.1038/onc.2013.176⟩
International audience; Prostate cancer (PCa) is one of the major public health problems in Western countries. Recently, the TMPRSS2:ERG gene fusion, which results in the aberrant expression of the transcription factor ERG, has been shown to be the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5d576f6a8be17c3a0773fdc727480c1
https://hal.archives-ouvertes.fr/hal-02353391
https://hal.archives-ouvertes.fr/hal-02353391